Home
Conditions
Nasopharyngeal Carcinoma

Clinical trial condition

Nasopharyngeal Carcinoma

Explore clinical trials studying Nasopharyngeal Carcinoma. Study availability and eligibility vary by location and protocol.

363 public trials 136 recruiting studies

Refine in advanced search Browse all conditions

Nasopharyngeal Carcinoma trial results

Completed

Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma

NCT00778908

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: People's Hospital of Guangxi Zhuang Autonomous Region Nanning, Guangxi, China

View Trial Details

Completed

A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839

NCT00212108

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: National University Hospital Singapore

View Trial Details

Completed

Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma

NCT01449942

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: XiangYa Hospital, Central South University Changsha, Hunan, China

View Trial Details

Completed

Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy

NCT00700440

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Completed

Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function

NCT00123864

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Cross Cancer Institute Edmonton, Alberta, Canada

View Trial Details

Completed

Swallowing Pattern of Patients With Nasopharyngeal Cancer Before and After Radiation Therapy: Longitudinal Study and Correction With Saliva Amount

NCT00173836

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: X-ray fluoroscopy Taipei, Taiwan

View Trial Details

Active, Not Recruiting

Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

NCT05813626

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Active, Not Recruiting

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

NCT05063552

Conditions: Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +45 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Epic Care-Dublin Dublin, California, United States

Epic Care Partners in Cancer Care Emeryville, California, United States

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States

View all 172 locations

View Trial Details

Active, Not Recruiting

Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

NCT02135042

Conditions: Carcinoma, DNA Virus Infections, Epstein-Barr Virus Infection, +22 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

The Kirklin Clinic at Acton Road Birmingham, Alabama, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn, California, United States

View all 215 locations

View Trial Details

Active, Not Recruiting

Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies

NCT04925544

Conditions: Carcinoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
Locations: Stanford University Stanford, California, United States

View Trial Details

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma trial results

Related conditions